IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1727
+0.0067 (4.04%)
At close: Apr 1, 2025, 4:00 PM
0.1799
+0.0072 (4.17%)
After-hours: Apr 1, 2025, 7:54 PM EDT

IN8bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-30.44-30.01-28.52-14.65-8.56
Upgrade
Depreciation & Amortization
2.662.51.10.790.09
Upgrade
Loss (Gain) From Sale of Assets
0.05----
Upgrade
Stock-Based Compensation
54.373.472.20.36
Upgrade
Other Operating Activities
----0.37
Upgrade
Change in Accounts Payable
-0.54-0.981.51-0.32-0.16
Upgrade
Change in Other Net Operating Assets
-0.880.78-1.68-1.520.77
Upgrade
Operating Cash Flow
-24.15-23.34-24.12-13.51-7.13
Upgrade
Capital Expenditures
-0.19-0.6-3.71-0.31-
Upgrade
Investing Cash Flow
-0.19-0.6-3.71-0.31-
Upgrade
Long-Term Debt Issued
----0.17
Upgrade
Long-Term Debt Repaid
-0.79-0.8-0.62-0.71-
Upgrade
Net Debt Issued (Repaid)
-0.79-0.8-0.62-0.710.17
Upgrade
Issuance of Common Stock
15.0727.849.636.360.51
Upgrade
Other Financing Activities
-0.09---2.69-1.43
Upgrade
Financing Cash Flow
14.1827.048.9932.9624.52
Upgrade
Net Cash Flow
-10.153.1-18.8419.1417.38
Upgrade
Free Cash Flow
-24.34-23.94-27.83-13.82-7.13
Upgrade
Free Cash Flow Per Share
-0.45-0.80-1.33-1.39-2.09
Upgrade
Levered Free Cash Flow
-12.12-12.53-16.25-9.06-3.15
Upgrade
Unlevered Free Cash Flow
-12.12-12.53-16.25-9.06-3.15
Upgrade
Change in Net Working Capital
0.56-0.16-0.712.58-1.75
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q